CNBC reports that Amazon Web Services (AWS) has launched general availability for Amazon Omics. This service helps researchers store and analyze omic data like sequences of DNA, RNA and proteins. The global genomic data analysis market size is expected to reach $2.15 billion by 2030. Amazon’s cloud unit has been working to close the gap in this field and provide researchers with the tools they need to analyze genetic data more efficiently.
Omic data refers to the study of various biological molecules such as DNA, RNA and proteins. These molecules play a crucial role in understanding how our bodies function and how diseases develop. By providing researchers with a platform to store and analyze this data, Amazon Omics is helping to advance our understanding of genetics.
The launch of Amazon Omics is part of AWS’s expansion into healthcare. While AWS doesn’t disclose revenue projections for particular services, the potential for growth in this market is significant. With the increasing importance of genetic research in healthcare, services like Amazon Omics are likely to play an increasingly important role in advancing our understanding of human health.
